KEYNOTE-010: Pembrolizumab versus docetaxel for advanced PD-L1-positive NSCLC

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD, from Lausanne University Hospital, Lausanne, Sw... Author: EMJ Added: 02/28/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts